Got distracted by biggest pharmaceutical companies.
- Johnson & Johnson – $56.1bn.
- Pfizer – $51.75bn.
- Roche – $49.23bn.
- Novartis – $47.45bn.
- Merck & Co. – $46.84bn.
- GlaxoSmithKline – $44.27bn.
- Sanofi – $40.46bn.
- AbbVie – $33.26bn.
Any of those above that feel they're behind Novartis in Pecking order I'm sure Mesoblast management will consider say a $200M no strings attached cheque for last bid option on indication of their choice!
!
Mesoblast Partnership Announcements, page-77
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |